ICTHIOVAC VNN
ICTHIOVAC VNN
Not authorised
- Redspotted grouper nervous necrosis virus, strain 1103, Inactivated
Product identification
Medicine name:
ICTHIOVAC VNN RPS>60% ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
ICTHIOVAC VNN
Active substance:
- Redspotted grouper nervous necrosis virus, strain 1103, Inactivated
Target species:
-
Seabass
Route of administration:
-
Intraperitoneal use
Product details
Active substance and strength:
-
Redspotted grouper nervous necrosis virus, strain 1103, Inactivated1.00/Relative Percentage Survival1.00Dose
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intraperitoneal use
-
Seabass
-
All relevant tissuesno withdrawal periodWithdrawal period is 0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI10X
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Surrendered
Authorised in:
-
Greece
Package description:
- Vial of 5000 doses (5000 doses)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 70902/06-06-2019/K-0235401
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0349/001/DC
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 11/12/2024
How useful was this page?:
